A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease

Clinical trial NCT06810960 · RECRUITING

Trial details

NCT number: NCT06810960
Sponsor: Eisai Korea Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Alzheimer's Disease

Start date: 2025-02-24
Primary completion: 2029-09-30
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.